Screening with mammography v usual care to prevent breast cancer mortality at mean 14 years follow up*

Age groupsNumber of trials†RRR (95% CrI)NNS (CrI)
*CrI = credible interval; NNS = number needed to screen. Other abbreviations defined in glossary.
†The meta-analysis excluded the trial rated as poor quality.
All ages (39–74 y)716% (9 to 23)1224 (665 to 2564)
<50 years715% (1 to 27)1792 (674 to 10 540)
≥50 years722% (13 to 30)838 (494 to 1676)